Eli M. Wallace - Concepedia

Author

Eli M. Wallace

Array BioPharma (United States)

Also Known As

Eli M. Wallace

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Array BioPharma (United States)Cellerant Therapeutics (United States)The University of Texas Southwestern Medical Center Novartis (United States)Colorado State University

About

Eli M. Wallace is an author at Array BioPharma (United States) specializing in pharmacology, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.9K
2	Natural Sciences	7	7	491
3	Biochemistry	6	6	361
4	Engineering	5	5	381
5	Biomolecular Engineering	4	4	352

Eli M. Wallace

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Targeting renal cell carcinoma with a HIF-2 antagonist Wenfang Chen, Haley Hill, Alana Christie, Nature UrologyGenitourinary CancerRenal Cell CarcinomaAnti-cancer AgentMedicine	2016	697
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models Hyejin Cho, Xinlin Du, James P. Rizzi, Nature UrologyOncologyHif-2α AntagonistGenitourinary CancerKidney Research	2016	441
Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma Kevin D. Courtney, Jeffrey R. Infante, Elaine T. Lam, Journal of Clinical Oncology Peripheral EdemaTumor BiologyConclusion Pt2385UrologyGenitourinary Cancer	2017	369
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma Eli M. Wallace, James P. Rizzi, Guangzhou Han, Cancer Research	2016	310
Synthetic Routes to Allenic Acids and Esters and Their Stereospecific Conversion to Butenolides James A. Marshall, Mark A. Wolf, Eli M. Wallace The Journal of Organic Chemistry Novel OrganocatalystsEngineeringTheir Stereospecific ConversionOrganic ChemistryAcid 18	1997	186
Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors James F. Blake, Rui Xu, Josef R. Bencsik, Journal of Medicinal Chemistry Human TumorsTumor BiologyMedicinal ChemistryProtein Kinase B/aktDownstream Biomarkers	2012	184
Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820 Xinlin Du, Oleg A. Volkov, Robert Czerwiński, Structure BiochemistryProtein AssemblyNatural SciencesKinetic PathwayMolecular Biology	2019	171
Total Synthesis of the Pseudopterane (.+-.)-Kallolide B James A. Marshall, Eli M. Wallace, Paul S. Coan The Journal of Organic Chemistry Molecular SciencesChemical AnalysisAltmetric Attention ScoreChemometricsTotal Synthesis	1995	147
Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension Cheng‐Jun Hu, Jens M. Poth, Hui Zhang, European Respiratory Journal	2019	113
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (<i>S</i>)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1<i>H</i>-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385) Paul M. Wehn, James P. Rizzi, Darryl D. Dixon, Journal of Medicinal Chemistry	2018	108

Page 1